000277321 001__ 277321
000277321 005__ 20250323000920.0
000277321 0247_ $$2doi$$a10.3390/life15020177
000277321 0247_ $$2pmid$$apmid:40003586
000277321 0247_ $$2altmetric$$aaltmetric:173542985
000277321 037__ $$aDZNE-2025-00384
000277321 041__ $$aEnglish
000277321 082__ $$a570
000277321 1001_ $$00000-0002-1108-2174$$aÁlvarez-Salvago, Francisco$$b0
000277321 245__ $$aAssessing the Relationship of Different Levels of Pain to the Health Status of Long-Term Breast Cancer Survivors: A Cross-Sectional Study.
000277321 260__ $$aBasel$$bMDPI$$c2025
000277321 3367_ $$2DRIVER$$aarticle
000277321 3367_ $$2DataCite$$aOutput Types/Journal article
000277321 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1740585518_16241
000277321 3367_ $$2BibTeX$$aARTICLE
000277321 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000277321 3367_ $$00$$2EndNote$$aJournal Article
000277321 520__ $$aPurpose: This study investigated the relationship between different pain levels in the affected arm and health status in long-term breast cancer survivors (LTBCSs) and identified predictors of pain at this stage of long-term survivorship. Methods: A cross-sectional study of 80 participants categorized LTBCSs by pain levels in the affected arm into three groups: no pain (0-0.99), mild pain (1-3.99), and moderate to severe pain (4-10). Variables assessed at least 5 years since diagnosis include pain in the non-affected arm, pain interference, cancer-related fatigue (CRF), physical activity (PA) level, fitness condition, mood state, and health-related quality of life (HRQoL). Results: A total of 36.25% of LTBCSs have no pain, 30% have mild pain, and 33.75% have moderate to severe pain. Furthermore, pain presence was associated with increased pain in the non-affected arm, pain interference, CRF, mood disturbances, and physical inactivity, as well as a decreased HRQoL (all p < 0.05). Regression analysis found 'upset by hair loss', CRF 'affective domain', 'dyspnea', and 'alcohol consumption' as significant predictors of higher levels of pain in the affected arm (r2 adjusted = 0.646). Conclusions: A total of 63.75% of LTBCSs continue to experience mild to moderate to severe pain in the affected arm, negatively impacting their physical, mental, and emotional health status, with increased pain severity ≥5 years beyond cancer diagnosis. 'Upset by hair loss', CRF 'affective domain', 'dyspnea', and alcohol consumption collectively explain 64.6% of the affected-arm pain level in LTBCSs.
000277321 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000277321 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000277321 650_7 $$2Other$$abreast cancer
000277321 650_7 $$2Other$$along-term survivorship
000277321 650_7 $$2Other$$apain
000277321 650_7 $$2Other$$aquality of life
000277321 650_7 $$2Other$$arehabilitation
000277321 7001_ $$00009-0006-5675-8146$$aFigueroa-Mayordomo, Maria$$b1
000277321 7001_ $$00000-0003-4965-5721$$aMolina-García, Cristina$$b2
000277321 7001_ $$00000-0002-1736-3209$$aPujol-Fuentes, Clara$$b3
000277321 7001_ $$aAtienzar-Aroca, Sandra$$b4
000277321 7001_ $$00000-0003-0411-7030$$ade Diego-Moreno, Manuel$$b5
000277321 7001_ $$0P:(DE-2719)2812323$$aMedina Luque, Jose$$b6$$eLast author
000277321 770__ $$aPhysical Medicine and Rehabilitation: Trends and Applications—3rd Edition
000277321 773__ $$0PERI:(DE-600)2662250-6$$a10.3390/life15020177$$gVol. 15, no. 2, p. 177 -$$n2$$p177$$tLife$$v15$$x2075-1729$$y2025
000277321 8564_ $$uhttps://pub.dzne.de/record/277321/files/DZNE-2025-00384_SUPP.zip
000277321 8564_ $$uhttps://pub.dzne.de/record/277321/files/DZNE-2025-00384.pdf$$yOpenAccess
000277321 8564_ $$uhttps://pub.dzne.de/record/277321/files/DZNE-2025-00384.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000277321 909CO $$ooai:pub.dzne.de:277321$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000277321 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812323$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000277321 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000277321 9141_ $$y2025
000277321 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000277321 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLIFE-BASEL : 2022$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:28:09Z
000277321 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:28:09Z
000277321 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-12
000277321 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-12
000277321 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000277321 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-12
000277321 9201_ $$0I:(DE-2719)1110001$$kAG Herms$$lTranslational Brain Research$$x0
000277321 980__ $$ajournal
000277321 980__ $$aVDB
000277321 980__ $$aUNRESTRICTED
000277321 980__ $$aI:(DE-2719)1110001
000277321 9801_ $$aFullTexts